Bandara, Geethani <br/><br/>
Targeting Sphingosine Kinase Isoforms Effectively Reduces Growth and Survival of Neoplastic Mast Cells With D816V-KIT.  [electronic resource] 

 -  Frontiers in immunology  2018 
 - 631 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1664-3224 
<br/><br/><label>Standard No.: </label>10.3389/fimmu.2018.00631  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adamantane--analogs & derivatives<br/>Animals<br/>Apoptosis<br/>Carcinogenesis<br/>Cell Proliferation<br/>Cell Survival<br/>DNA Repair<br/>Hematologic Neoplasms--genetics<br/>Humans<br/>Hydrazines--pharmacology<br/>Mast Cells--physiology<br/>Mastocytosis--genetics<br/>Mice<br/>Mice, Knockout<br/>Mutation--genetics<br/>Phosphotransferases (Alcohol Group Acceptor)--antagonists & inhibitors<br/>Protein Isoforms--antagonists & inhibitors<br/>Proto-Oncogene Proteins c-kit--genetics<br/>Pyrazoles--pharmacology<br/>Pyridines--pharmacology<br/>Tumor Cells, Cultured<br/>Xenograft Model Antitumor Assays